K. David Campagnari
Presidente en Induce Biologics, Inc. .
Perfil
K.
David Campagnari is currently the President & Chief Operating Officer at Induce Biologics, Inc. He previously worked as the Vice President-Operations at MIGENIX, Inc. from 2002 to 2010.
He received his undergraduate degree and MBA from National University.
Cargos activos de K. David Campagnari
| Empresas | Cargo | Inicio |
|---|---|---|
Induce Biologics, Inc.
 Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | Presidente | - |
Antiguos cargos conocidos de K. David Campagnari.
| Empresas | Cargo | Fin |
|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director de Operaciones | 24/03/2010 |
Formación de K. David Campagnari.
| National University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Induce Biologics, Inc.
Induce Biologics, Inc. BiotechnologyHealth Technology Induce Biologics, Inc. is a medicine company. The firm is develops bio implants for bone regeneration. It also offers URIST product. The company was founded by Sean Peel and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- K. David Campagnari
